Furey John 4
4 · Spark Therapeutics, Inc. · Filed Apr 24, 2018
Insider Transaction Report
Form 4
Furey John
Chief Operating Officer
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2018-04-20−6,723→ 120,000 totalExercise: $49.74Exp: 2026-11-30→ Common Stock (6,723 underlying) - Exercise/Conversion
Common Stock
2018-04-20$49.74/sh+6,723$334,402→ 6,723 total - Sale
Common Stock
2018-04-20$82.50/sh−6,723$554,648→ 0 total
Footnotes (2)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2017.
- [F2]25% vests December 1, 2017 and the remainder vests in equal quarterly installments over the following three years following December 1, 2017.